+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Drug Market - Global Forecast 2026-2032- Product Image
Veterinary Drug Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary Drug Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986087
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Drug Market is projected to reach USD 48.57 Billion in 2026. It is expected to continue growing at a CAGR of 8.70%, reaching USD 80.31 Billion by 2032.

The veterinary drug market is a critical pillar of animal health, food security, companion animal care, and One Health policy. Demand is supported by the medical needs of livestock, poultry, aquaculture, equine, and companion animals, while regulatory oversight from agencies such as the U.S. FDA Center for Veterinary Medicine, USDA APHIS, the European Medicines Agency, and national authorities continues to shape product quality, safety, efficacy, and pharmacovigilance.

Growth in veterinary pharmaceuticals is being driven by the rising burden of infectious and parasitic diseases, higher pet health spending, expanding animal protein consumption, and the need to protect herd productivity. According to WOAH, animal diseases can affect livestock production, trade continuity, and public health, reinforcing the importance of approved veterinary medicines, vaccines, diagnostics-linked treatment, and responsible antimicrobial use. At the same time, the market is shifting toward preventive care, prescription parasiticides, targeted anti-infective stewardship, dermatology therapies, pain management, reproductive health products, and species-specific formulations that align with modern veterinary practice.

Transformative Shifts in the Veterinary Drug Landscape

The veterinary drug landscape is transforming as animal health moves from reactive treatment to prevention, surveillance, and precision care. Regulations such as FDA Guidance for Industry #263, which moved remaining over-the-counter medically important antimicrobials for animals under veterinary oversight in the United States, and Regulation (EU) 2019/6, which strengthened antimicrobial-use controls in Europe, are accelerating responsible prescribing and stewardship.

Manufacturers are also adapting to changes in distribution and care delivery. E-commerce, veterinary clinic networks, telehealth-supported prescribing where permitted, and direct relationships with producers are reshaping access to approved products. Across livestock and companion animal segments, the strongest positioning is shifting toward portfolios that combine clinical efficacy, regulatory compliance, residue management, ease of administration, cold-chain reliability, and measurable outcomes.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the veterinary drug value chain, with the highest near-term impact in drug discovery, target identification, clinical trial design, pharmacovigilance, diagnostic decision support, and precision livestock health. AI-enabled models can help screen compounds, analyze real-world evidence, detect adverse event patterns, and connect diagnostic data with treatment protocols, provided that datasets are validated and compliant with applicable data protection, quality management, and veterinary regulations.

In commercial practice, AI is strengthening disease surveillance through herd monitoring, wearable sensors, imaging tools, laboratory data, and production analytics. These capabilities support earlier intervention, better antimicrobial stewardship, improved inventory planning, and more consistent treatment decisions. The cumulative impact is not the replacement of veterinarians, but the creation of evidence-led workflows that help veterinarians, producers, and pet owners use veterinary drugs more responsibly and effectively.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-priority growth region because China, India, Japan, South Korea, Australia, and ASEAN markets combine large livestock populations, expanding pet ownership, and active aquaculture production. FAOSTAT and national agricultural datasets consistently show the region's scale in poultry, swine, dairy, and aquaculture, making disease prevention, vaccines, parasiticides, and anti-infective stewardship central to demand. The region also faces recurring pressure from transboundary animal diseases, which increases the strategic importance of surveillance, biosecurity, veterinary biologics, and regulated access to essential medicines.

North America remains one of the most regulated and innovation-led veterinary drug markets, supported by strong companion animal spending, advanced livestock production, and defined oversight from FDA CVM, USDA APHIS, Health Canada, and state-level veterinary boards. Latin America, led by Brazil and Mexico, is closely tied to beef, poultry, swine, and export-oriented protein supply chains, where residue compliance, disease control, and herd health programs are essential to market access and productivity.

Europe is shaped by rigorous pharmacovigilance, antimicrobial controls, and sustainability requirements under EU and national frameworks, with Regulation (EU) 2019/6 reinforcing prudent use of veterinary medicinal products. The Middle East is expanding demand through food security investments, dairy and poultry modernization, camel and equine health, and companion animal care in urban centers. Africa presents long-term potential linked to livestock disease control, vaccine access, public-sector programs, and the need to reduce productivity losses associated with endemic and transboundary animal diseases, including those prioritized by WOAH and national veterinary services.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are benefiting from poultry, aquaculture, and swine modernization, with demand concentrated in vaccines, parasiticides, biosecurity-linked therapies, and approved anti-infectives. Disease prevention is especially important in dense production systems, while national antimicrobial resistance action plans are increasing attention on veterinary oversight and responsible use. GCC countries are investing in food security, dairy production, camel and equine health, and regulated import pathways, creating opportunities for premium veterinary products, biologics, diagnostics-linked treatment, and cold-chain distribution.

The European Union remains a benchmark for veterinary drug regulation, particularly through Regulation (EU) 2019/6 and coordinated pharmacovigilance, which influence product authorization, antimicrobial stewardship, and post-market monitoring. BRICS markets combine major animal protein production, large companion animal populations, and diverse regulatory maturity, making local registration strategy, quality compliance, and manufacturing partnerships important. G7 markets are characterized by advanced veterinary infrastructure, high compliance expectations, and strong innovation adoption, while NATO countries overlap with many high-income regulated markets where supply resilience, biosecurity, and public health preparedness influence animal health policy and veterinary medicine availability.

Key Country Insights Across Major Veterinary Drug Markets

The United States leads in veterinary drug innovation, regulatory clarity, and companion animal therapeutics, with FDA CVM and USDA APHIS providing distinct oversight for drugs and biologics. Canada has a mature animal health system with strong livestock and companion animal demand, supported by federal veterinary drug review and food safety controls. Mexico links veterinary drug use to poultry, swine, cattle, and cross-border protein trade, where disease management and residue compliance remain central. Brazil is a strategic market because it is one of the world's most important beef and poultry exporters, making disease control, vaccination, parasiticide use, and export-compliant residue management commercially critical.

The United Kingdom, Germany, France, Italy, and Spain combine advanced veterinary services with strict European antimicrobial and pharmacovigilance standards, supporting demand for approved companion animal medicines, livestock vaccines, dermatology products, pain therapies, and preventive health solutions. Russia has substantial livestock production and domestic supply priorities, increasing the importance of local registration, supply continuity, and disease control. China and India are scale markets with significant livestock, aquaculture, and companion animal opportunities, though registration pathways, pricing dynamics, and local competition require careful market entry planning. Japan, Australia, and South Korea are high-compliance markets where premium companion animal therapies, vaccines, parasiticides, biosecurity, and evidence-based prescribing are especially important.

Actionable Recommendations for Veterinary Drug Industry Leaders

Industry leaders should prioritize regulatory-ready portfolios that align with antimicrobial stewardship, residue requirements, pharmacovigilance obligations, and Good Manufacturing Practice expectations. Investment should focus on vaccines, parasiticides, dermatology, pain management, chronic disease therapies, reproductive health, and species-specific formulations where clinical need and owner or producer willingness to pay are clear.

Companies should strengthen local registration expertise, diversify manufacturing and active ingredient sourcing, and build resilient cold-chain and clinic-facing distribution. Partnerships with veterinarians, producer groups, diagnostic providers, universities, and digital health providers can improve adoption, generate real-world evidence, and support differentiated value propositions in both livestock and companion animal segments. Leaders should also embed antimicrobial stewardship metrics, adverse event monitoring, and product education into commercialization to strengthen trust with regulators, veterinarians, producers, and pet owners.

Research Methodology

The research methodology combines secondary research from regulatory agencies, veterinary associations, intergovernmental organizations, scientific literature, trade databases, and public disclosures with structured market interpretation. Key sources include FDA CVM, USDA APHIS, EMA, national veterinary authorities, WOAH, FAO, WHO, Codex Alimentarius guidance, antimicrobial resistance action plans, and peer-reviewed animal health research.

Market assessment is developed through triangulation of regulatory developments, disease burden indicators, animal population trends, livestock production patterns, companion animal care dynamics, product approvals, distribution shifts, and expert-led validation. This approach supports data-backed insights without relying on unverified assumptions, unsupported market claims, market sizing, market share statements, or forecasting.

Conclusion

The veterinary drug market is becoming more prevention-driven, regulated, digitally enabled, and outcome-focused. Companies that combine scientific credibility, responsible antimicrobial practices, reliable supply, strong pharmacovigilance, and region-specific commercialization strategies are best positioned to capture growth.

As animal health becomes more closely linked to food security, public health, trade continuity, and sustainability, veterinary drug manufacturers must deliver products that meet clinical, regulatory, and economic expectations. The strongest opportunities will favor organizations that convert evidence, compliance, and innovation into trusted therapeutic value for veterinarians, producers, and pet owners.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Drug Market, by Product Category
7.1. Introduction
7.2. Anti-Infectives
7.2.1. Antibiotics
7.2.2. Antifungals
7.2.3. Antivirals
7.3. Anti-Inflammatories
7.4. Parasiticides
7.4.1. Ectoparasiticides
7.4.2. Endoparasiticides
7.4.3. Endectocides
7.5. Vaccines
7.5.1. Core Vaccines
7.5.2. Non-Core Vaccines
7.5.3. Autogenous Vaccines
7.6. Anti-Inflammatory & Pain Management
7.6.1. NSAIDs
7.6.2. Corticosteroids
7.6.3. Analgesics
7.7. Hormones & Reproductive Health
7.8. Dermatology
7.9. Gastrointestinal
7.9.1. Antiemetics
7.9.2. Antidiarrheals
8. Veterinary Drug Market, by Route Of Administration
8.1. Introduction
8.2. Inhalation
8.3. Parenteral
8.3.1. Intramuscular
8.3.2. Subcutaneous
8.3.3. Intravenous
8.3.4. Intradermal
8.4. Oral
8.4.1. Tablets & Capsules
8.4.2. Oral Liquids
8.4.3. Chewables
8.4.4. Medicated Feed & Water
8.5. Topical
8.5.1. Creams & Ointments
8.5.2. Sprays
8.6. Ophthalmic
9. Veterinary Drug Market, by Distribution Channel
9.1. Introduction
9.2. Online Pharmacies
9.3. Retail Pharmacies
9.4. Veterinary Hospitals
9.5. Feed & Farm Supply Stores
9.6. Government & Institutional Procurement
10. Veterinary Drug Market, by Animal Type
10.1. Introduction
10.2. Companion Animals
10.2.1. Dogs
10.2.2. Cats
10.2.3. Small Mammals
10.2.3.1. Rabbits
10.2.3.2. Guinea Pigs
10.2.3.3. Ferrets
10.2.4. Birds
10.2.4.1. Psittacines
10.2.4.2. Passerines
10.2.5. Exotics
10.2.5.1. Reptiles
10.2.5.2. Amphibians
10.3. Livestock Animals
10.3.1. Cattle
10.3.1.1. Dairy Cattle
10.3.1.2. Beef Cattle
10.3.2. Swine
10.3.2.1. Breeding Swine
10.3.2.2. Finisher Swine
10.3.3. Poultry
10.3.3.1. Broilers
10.3.3.2. Layers
10.3.4. Small Ruminants
10.3.4.1. Sheep
10.3.4.2. Goats
10.3.5. Aquaculture
10.3.5.1. Freshwater
10.3.5.2. Marine
10.4. Equines
10.4.1. Horses
10.4.2. Donkeys & Mules
10.5. Laboratory Animals
10.6. Zoo & Wildlife Animals
11. Veterinary Drug Market, by Disease Indication
11.1. Introduction
11.2. Infectious Diseases
11.3. Dermatological Disorders
11.4. Respiratory Disorders
11.5. Gastrointestinal Disorders
11.6. Musculoskeletal Disorders
11.7. Reproductive Disorders
11.8. Neurological Disorders
11.9. Ophthalmic Disorders
12. Veterinary Drug Market, by Care Setting
12.1. Introduction
12.2. Companion Animal Practice
12.3. Livestock Production Operations
12.4. Aquaculture Farms
12.5. Research Institutions
12.6. Shelters & Rescue Organizations
12.7. Zoos & Wildlife Centers
13. Veterinary Drug Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Veterinary Drug Market, by Group
14.1. NATO
14.2. G7
14.3. European Union
14.4. BRICS
14.5. ASEAN
14.6. GCC
15. Veterinary Drug Market, by Country
15.1. United States
15.2. China
15.3. Germany
15.4. Japan
15.5. India
15.6. United Kingdom
15.7. France
15.8. Canada
15.9. Italy
15.10. Australia
15.11. South Korea
15.12. Brazil
15.13. Mexico
15.14. Russia
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Zoetis Inc.
17.2. Merck & Co., Inc.
17.3. Boehringer Ingelheim International GmbH
17.4. Elanco Animal Health Incorporated
17.5. Ceva Santé Animale
17.6. Virbac S.A.
17.7. Dechra Pharmaceuticals PLC
17.8. Phibro Animal Health Corporation
17.9. Norbrook Group
17.10. Vetoquinol Group
17.11. Neogen Corporation
17.12. Chanelle Pharma
17.13. Aurora Pharmaceutical, Inc.
17.14. Biogénesis Bagó S.A.
17.15. Biovac Ltd.
17.16. China Animal Husbandry Industry Co., Ltd.
17.17. ECO Animal Health Group PLC
17.18. Heska Corporation by Mars, Incorporated
17.19. Hester Biosciences Limited
17.20. Indian Immunologicals Ltd.
17.21. Intas Pharmaceuticals Ltd.
17.22. Laboratorio Drag Pharma Chile Invetec S.A.
17.23. Teknofarma S.r.l.
17.24. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
17.25. Zendal Group
List of Figures
FIGURE 1. GLOBAL VETERINARY DRUG MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VETERINARY DRUG MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VETERINARY DRUG MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VETERINARY DRUG MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VETERINARY DRUG MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VETERINARY DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VETERINARY DRUG MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ANTIFUNGALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ANTIFUNGALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ANTIFUNGALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ANTIVIRALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ANTIVIRALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIVIRALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ENDECTOCIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ENDECTOCIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ENDECTOCIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CORE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CORE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CORE VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL NON-CORE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL NON-CORE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL NON-CORE VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL AUTOGENOUS VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL AUTOGENOUS VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL AUTOGENOUS VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ANTI-INFLAMMATORY & PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ANTI-INFLAMMATORY & PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ANTI-INFLAMMATORY & PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL NSAIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NSAIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL NSAIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ANALGESICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HORMONES & REPRODUCTIVE HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HORMONES & REPRODUCTIVE HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL HORMONES & REPRODUCTIVE HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DERMATOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL GASTROINTESTINAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL GASTROINTESTINAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL GASTROINTESTINAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ANTIEMETICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ANTIEMETICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ANTIEMETICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ANTIDIARRHEALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ANTIDIARRHEALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ANTIDIARRHEALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL INHALATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL INTRADERMAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL INTRADERMAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL INTRADERMAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ORAL LIQUIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ORAL LIQUIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ORAL LIQUIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL CHEWABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CHEWABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CHEWABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL MEDICATED FEED & WATER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL MEDICATED FEED & WATER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL MEDICATED FEED & WATER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL OPHTHALMIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL OPHTHALMIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL OPHTHALMIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL FEED & FARM SUPPLY STORES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL FEED & FARM SUPPLY STORES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL FEED & FARM SUPPLY STORES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL GOVERNMENT & INSTITUTIONAL PROCUREMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL GOVERNMENT & INSTITUTIONAL PROCUREMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL GOVERNMENT & INSTITUTIONAL PROCUREMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL SMALL MAMMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL SMALL MAMMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL SMALL MAMMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL RABBITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL RABBITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL RABBITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL GUINEA PIGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL GUINEA PIGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL GUINEA PIGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL FERRETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL FERRETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL FERRETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL BIRDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL PSITTACINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL PSITTACINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL PSITTACINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL PASSERINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL PASSERINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL PASSERINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL EXOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL EXOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL EXOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL REPTILES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL REPTILES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL REPTILES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL AMPHIBIANS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL AMPHIBIANS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL AMPHIBIANS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL DAIRY CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL DAIRY CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL DAIRY CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL BEEF CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL BEEF CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL BEEF CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL BREEDING SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 188. GLOBAL BREEDING SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 189. GLOBAL BREEDING SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 190. GLOBAL FINISHER SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 191. GLOBAL FINISHER SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL FINISHER SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 193. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 194. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 195. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 196. GLOBAL BROILERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 197. GLOBAL BROILERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 198. GLOBAL BROILERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 199. GLOBAL LAYERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 200. GLOBAL LAYERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 201. GLOBAL LAYERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 202. GLOBAL SMALL RUMINANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 203. GLOBAL SMALL RUMINANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. GLOBAL SMALL RUMINANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 205. GLOBAL SHEEP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 208. GLOBAL GOATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 209. GLOBAL GOATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 210. GLOBAL GOATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 211. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 212. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 214. GLOBAL FRESHWATER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 215. GLOBAL FRESHWATER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 216. GLOBAL FRESHWATER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 217. GLOBAL MARINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 218. GLOBAL MARINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 219. GLOBAL MARINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 220. GLOBAL EQUINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 221. GLOBAL EQUINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. GLOBAL EQUINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 223. GLOBAL HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 224. GLOBAL HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 225. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 226. GLOBAL DONKEYS & MULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 227. GLOBAL DONKEYS & MULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. GLOBAL DONKEYS & MULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 229. GLOBAL LABORATORY ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 230. GLOBAL LABORATORY ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 231. GLOBAL LABORATORY ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 232. GLOBAL ZOO & WILDLIFE ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 233. GLOBAL ZOO & WILDLIFE ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 234. GLOBAL ZOO & WILDLIFE ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 235. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 236. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 237. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 238. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 239. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 240. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 241. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 242. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 243. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 244. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 245. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 246. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 248. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 249. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 250. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 251. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 252. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 253. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 254. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 255. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 256. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 257. GLOBAL OPHTHALMIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 258. GLOBAL OPHTHALMIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 259. GLOBAL OPHTHALMIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 260. GLOBAL VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 261. GLOBAL COMPANION ANIMAL PRACTICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 262. GLOBAL COMPANION ANIMAL PRACTICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. GLOBAL COMPANION ANIMAL PRACTICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 264. GLOBAL LIVESTOCK PRODUCTION OPERATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 265. GLOBAL LIVESTOCK PRODUCTION OPERATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 266. GLOBAL LIVESTOCK PRODUCTION OPERATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 267. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 268. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 269. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 270. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 271. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 272. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 273. GLOBAL SHELTERS & RESCUE ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 274. GLOBAL SHELTERS & RESCUE ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 275. GLOBAL SHELTERS & RESCUE ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 276. GLOBAL ZOOS & WILDLIFE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 277. GLOBAL ZOOS & WILDLIFE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 278. GLOBAL ZOOS & WILDLIFE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 279. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 280. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 281. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 282. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 283. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 284. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 285. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 286. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 287. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 288. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 289. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 290. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 291. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 292. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 293. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 294. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2017-2032 (USD MILLION)
TABLE 295. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY BIRDS, 2017-2032 (USD MILLION)
TABLE 296. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2017-2032 (USD MILLION)
TABLE 297. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 298. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY CATTLE, 2017-2032 (USD MILLION)
TABLE 299. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY SWINE, 2017-2032 (USD MILLION)
TABLE 300. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY POULTRY, 2017-2032 (USD MILLION)
TABLE 301. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2017-2032 (USD MILLION)
TABLE 302. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 303. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY EQUINES, 2017-2032 (USD MILLION)
TABLE 304. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 305. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 306. EUROPE VETERINARY DRUG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 307. EUROPE VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 308. EUROPE VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 309. EUROPE VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 310. EUROPE VETERINARY DRUG MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 311. EUROPE VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 312. EUROPE VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 313. EUROPE VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 314. EUROPE VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 315. EUROPE VETERINARY DRUG MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 316. EUROPE VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 317. EUROPE VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 318. EUROPE VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 319. EUROPE VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 320. EUROPE VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2017-2032 (USD MILLION)
TABLE 321. EUROPE VETERINARY DRUG MARKET SIZE, BY BIRDS, 2017-2032 (USD MILLION)
TABLE 322. EUROPE VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2017-2032 (USD MILLION)
TABLE 323. EUROPE VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 324. EUROPE VETERINARY DRUG MARKET SIZE, BY CATTLE, 2017-2032 (USD MILLION)
TABLE 325. EUROPE VETERINARY DRUG MARKET SIZE, BY SWINE, 2017-2032 (USD MILLION)
TABLE 326. EUROPE VETERINARY DRUG MARKET SIZE, BY POULTRY, 2017-2032 (USD MILLION)
TABLE 327. EUROPE VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2017-2032 (USD MILLION)
TABLE 328. EUROPE VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 329. EUROPE VETERINARY DRUG MARKET SIZE, BY EQUINES, 2017-2032 (USD MILLION)
TABLE 330. EUROPE VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 331. EUROPE VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 332. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 333. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 334. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 335. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 336. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 337. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 338. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 339. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 340. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 341. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 342. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 343. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 344. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 345. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 346. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2017-2032 (USD MILLION)
TABLE 347. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY BIRDS, 2017-2032 (USD MILLION)
TABLE 348. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2017-2032 (USD MILLION)
TABLE 349. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 350. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY CATTLE, 2017-2032 (USD MILLION)
TABLE 351. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY SWINE, 2017-2032 (USD MILLION)
TABLE 352. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2017-2032 (USD MILLION)
TABLE 353. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2017-2032 (USD MILLION)
TABLE 354. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 355. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY EQUINES, 2017-2032 (USD MILLION)
TABLE 356. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 357. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 358. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 359. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 360. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 361. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 362. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 363. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 364. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 365. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 366. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 367. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 368. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 369. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 370. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 371. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 372. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2017-2032 (USD MILLION)
TABLE 373. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY BIRDS, 2017-2032 (USD MILLION)
TABLE 374. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2017-2032 (USD MILLION)
TABLE 375. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 376. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY CATTLE, 2017-2032 (USD MILLION)
TABLE 377. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY SWINE, 2017-2032 (USD MILLION)
TABLE 378. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2017-2032 (USD MILLION)
TABLE 379. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2017-2032 (USD MILLION)
TABLE 380. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 381. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY EQUINES, 2017-2032 (USD MILLION)
TABLE 382. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 383. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 384. AFRICA VETERINARY DRUG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 385. AFRICA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 386. AFRICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 387. AFRICA VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 388. AFRICA VETERINARY DRUG MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 38

Companies Mentioned

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale
  • Virbac S.A.
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Norbrook Group
  • Vetoquinol Group
  • Neogen Corporation
  • Chanelle Pharma
  • Aurora Pharmaceutical, Inc.
  • Biogénesis Bagó S.A.
  • Biovac Ltd.
  • China Animal Husbandry Industry Co., Ltd.
  • ECO Animal Health Group PLC
  • Heska Corporation by Mars, Incorporated
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec S.A.
  • Teknofarma S.r.l.
  • Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • Zendal Group

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 48.57 Billion
Forecasted Market Value ( USD ) by 2032 $ 80.31 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Veterinary Therapeutics Market - Global Forecast 2026-2032 - Product Image

Veterinary Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 2, 2027) - Product Image

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 2, 2027)

  • Training
  • 1 Day
  • Global
Veterinary Pharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Veterinary Pharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.